| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |